• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,000
83
62
59
47

COUNTRY

57
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 36
  • 12
  • 12
  • 12
  • 18

PRICE

556
820
1,700
2,700

PUBLISHED

9
159
653
2,700

PRODUCT TYPE

2,593
87
12
7
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015" provides...

February 2015
FROM

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Myxoid Liposarcoma clinical...

February 2015
FROM

Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015

Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015" provides data...

February 2015
FROM

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015" provides data on the...

February 2015
FROM

Thymus Carcinoma Global Clinical Trials Review, H1, 2015

Thymus Carcinoma Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Thymus Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Thymus Carcinoma clinical...

February 2015
FROM

Intestinal Cancer Global Clinical Trials Review, H1, 2015

Intestinal Cancer Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cancer clinical...

February 2015
FROM

Synovial Sarcoma Global Clinical Trials Review, H1, 2015

Synovial Sarcoma Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H1, 2015" provides data on the Synovial Sarcoma clinical...

February 2015
FROM

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market,...

February 2015
FROM

T-Cell Leukemia - Pipeline Review, H1 2015

T-Cell Leukemia - Pipeline Review, H1 2015 Summary This, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

February 2015
FROM

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015 Summary This, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas...

February 2015
FROM

Liposarcoma - Pipeline Review, H1 2015

Liposarcoma - Pipeline Review, H1 2015 Summary This ‘Liposarcoma - Pipeline Review, H1 2015’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015 Summary This ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015’, provides an overview of the Gastroesophageal...

February 2015
FROM

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015 Summary This ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015’, provides an overview of the Metastatic...

February 2015
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

February 2015
FROM

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary This ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic...

February 2015
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Chemotherapy Induced Anemia - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

February 2015
FROM

Medullary Thyroid Cancer - Pipeline Review, H1 2015

Medullary Thyroid Cancer - Pipeline Review, H1 2015 Summary This ‘Medullary Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline. This...

February 2015
FROM

Sezary Syndrome Global Clinical Trials Review, H1, 2015

Sezary Syndrome Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Sezary Syndrome clinical...

February 2015
FROM

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1,...

February 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)